thanks for posting. just to correct your typo, price target was lowered from $36 to $33 (so down, not up). so slight downgrade but as you say they still maintain outperform rating. this seems reasonable given what I've read here that most us analysts had higher sales for daybue in 2024 and therefore 2025. I would imagine this could also translate into slight downgrades by aus analysts for neuren but think I read here that the aus analysts were using lower figures. So maybe minor downgrade in PT for neuren but by and far the new target will result still result in a strong buy for neuren given its sitting at $19. market clearly over reacted.
thanks for posting. just to correct your typo, price target was...
-
- There are more pages in this discussion • 607 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.13 |
Change
0.020(0.15%) |
Mkt cap ! $1.678B | |||
| Open | High | Low | Value | Volume |
| $13.20 | $13.44 | $13.07 | $5.021M | 378.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 11501 | $13.12 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.18 | 1539 | 1 |
View Market Depth
| Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
| NEU (ASX) Chart |